Sartorius

Dominique Baly has been appointed president of Sartorius’ group laboratory business, responsible for cross-divisional management of marketing, sales and service. Mr. Baly reports to the chief executive officer and is a member of the group executive committee that includes six executives of Sartorius AG and the subgroup Sartorius Stedim Biotech.

“With Dominique Baly, we are gaining an exceptionally experienced and successful manager for our team. He will give our laboratory business decisive momentum in this fast-evolving market environment to define the future positioning for significant growth,” said chief executive officer and executive board chairman, Dr. Joachim Kreuzburg.

Mr. Baly has more than 35 years of sales and managerial experience. He joins the company from Millipore Corp., which was acquired by Merck KGaA in 2010. From 2005 to 2008, he was president of the bioscience division. In 2009, he became chief executive officer of Accelerator Sciences LLC, a U.S. investment firm.